Mass. vitamin settlement
This article was originally published in The Tan Sheet
Fairness hearing slated for Aug. 28 in Cambridge state court on $19.6 mil. class action settlement of consumers' vitamin price-fixing claims against seven ingredient suppliers. Under the agreement tentatively approved April 22, settling defendants BASF, Daiichi Pharmaceutical, Eisai, Aventis Animal Nutrition, Hoffman-La Roche, Roche Vitamins and Takeda Chemical Industries deny liability. Settlement proceeds would be allocated to charitable groups providing food and nutrition programs in the state. Massachusetts consumers' indirect claims were not part of multi-state settlement involving the same defendants in October 2000 (1"The Tan Sheet" Oct. 16, 2000, p. 5)...
You may also be interested in...
Twenty-four states and U.S. jurisdictions will use $145.6 mil. in proceeds from vitamin price-fixing settlements to fund health, education and scientific programs such as prenatal care and nutrition research.
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.